Ticker SymbolIBB
Asset ClassEquity
Fund ManageriShares
DomicileUS
Expense Ratio0.44%
Founded at2001-02-05
Tracking IndexNYSE Biotechnology (TR)
IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 10778.45m in AUM and 237 holdings. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.